UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-Q

(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

                  For the quarterly period ended June 30, 2011

                                       or

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

         For the transition period from ___________ to ____________

                       Commission file number: 333-139669


                                   CYTTA CORP.
             (Exact name of Registrant as specified in its charter)

             Nevada                                              98-0505761
  (State or other jurisdiction                                 (IRS Employer
of incorporation or organization)                            Identification No.)

          Suite 101- 6490 West Desert Inn Road, Las Vegas Nevada 89146
                    (Address of principal executive offices)

                                 (702) 307-1680
              (Registrant's telephone number, including area code)

              (Former name, former address and former fiscal year,
                         if changed since last report)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  Registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted  electronically  and
posted on its corporate Web site, if any, every  Interactive  Data File required
to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss.232.405 of
this chapter)  during the  preceding 12 months (or for such shorter  period that
the registrant was required to submit and post such files). Yes [ ] No [X]

Indicate by check mark whether the Registrant is a large  accelerated  filer, an
accelerated filer, a non-accelerated  filer, or a smaller reporting company. See
the definitions of "large accelerated filer,"  "accelerated filer," and "smaller
reporting company" in Rule 12b-2 of the Exchange Act (Check one).

Large accelerated filer [ ]                        Accelerated filer [ ]

Non-accelerated filer [ ]                          Smaller reporting company [X]
(Do not check if a smaller reporting company)

Indicate by check mark whether the  Registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

As of August 15th, 2011, there were 1,328,078,203  shares of the issuer's common
stock, par value $0.00001, outstanding.

<PAGE>
                         PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

The accompanying unaudited financial statements have been prepared in accordance
with accounting  principles  generally  accepted in the United States of America
and the rules of the Securities and Exchange Commission  ("SEC"),  and should be
read in  conjunction  with the audited  financial  statements  and notes thereto
contained in the  Company's  September  30, 2010 Form 10-K filed with the SEC on
January 13, 2011. In the opinion of management,  all adjustments,  consisting of
normal  recurring  adjustments,  necessary for a fair  presentation of financial
position  and the  results of  operations  for the periods  presented  have been
reflected  herein.  The results of operations for the periods  presented are not
necessarily indicative of the results to be expected for the full year.


                                       2
<PAGE>
                                   Cytta Corp.
                          (A Development Stage Company)
                           Consolidated Balance Sheets

<TABLE>
<CAPTION>
                                                                       June 30,             September 30,
                                                                         2011                   2010
                                                                     ------------           ------------
                                                                      (Unaudited)
<S>                                                                  <C>                    <C>
                                     ASSETS

CURRENT ASSETS
  Cash and cash equivalents                                          $    214,593           $     19,927
  Inventory                                                                 5,440                     --
  Investment in joint venture                                              25,000                     --
  Prepaid fees and services                                                    --                 51,935
                                                                     ------------           ------------

      Total Current Assets                                                245,033                 71,862
                                                                     ------------           ------------

PROPERTY AND EQUIPMENT, net                                                 7,262                     --
                                                                     ------------           ------------

      TOTAL ASSETS                                                   $    252,295           $     71,862
                                                                     ============           ============

                      LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES
  Accounts payable and accrued liabilities                           $      8,739           $      9,272
  Due to related parties                                                  191,531                 53,026
                                                                     ------------           ------------

      TOTAL LIABILITIES                                                   200,270                 62,298
                                                                     ------------           ------------
STOCKHOLDERS' DEFICIT
  Authorized:
    100,000,000 preferred shares, $0.001 par value
    1,900,000,000 common shares, $0.00001 par value
  Issued and outstanding shares:
    1,328,078,203 and 1,078,078,203 common shares                          12,721                 10,221
  Additional paid-in capital                                              802,219                489,719
  Subscriptions payable                                                   568,000                     --
  Common shares pending cancellation                                          560                    560
  Deficit accumulated during the development stage                     (1,341,475)              (490,936)
                                                                     ------------           ------------
  Noncontrolling interest in joint venture                                 10,000                     --
                                                                     ------------           ------------

      Total Stockholders' Equity                                           52,025                  9,564
                                                                     ------------           ------------

      TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT                    $    252,295           $     71,862
                                                                     ============           ============
</TABLE>

                                       3
<PAGE>
                                   Cytta Corp.
                          (A Development Stage Company)
                      Consolidated Statements of Operations

<TABLE>
<CAPTION>
                                                                                                           Cumulative from
                                        For the Three Months Ended         For the Nine Months Ended         Inception on
                                                 June 30,                           June 30,               May 30, 2006 to
                                    --------------------------------   --------------------------------        June 30,
                                         2011              2010             2011              2010               2011
                                    --------------    --------------   --------------    --------------     --------------
<S>                                 <C>               <C>              <C>               <C>                <C>
REVENUES                            $        2,000    $           --   $        2,000    $           --     $        2,000

Cost of Goods Sold                           1,360                --            1,360                --              1,360
                                    --------------    --------------   --------------    --------------     --------------

      Gross Margin                             640                --              640                --                640

OPERATING EXPENSES
  Professional fees                         32,653            16,605          113,356            31,927            249,863
  Management fees                          113,028            45,000          362,504            52,662            501,389
  General and administrative                26,670             8,747           49,500            10,420            148,463
  Impairment of licensing agreement             --                --          325,000                --            441,581
                                    --------------    --------------   --------------    --------------     --------------

      Total Operating Expenses             172,351            70,352          850,360            95,009          1,341,296
                                    --------------    --------------   --------------    --------------     --------------

NET LOSS FROM OPERATIONS                  (171,711)          (70,352)        (849,720)          (95,009)        (1,340,656)

OTHER INCOME (EXPENSE)
  Interest income                               84                --              217                --                217
  Interest expense                            (325)             (234)          (1,036)             (381)            (1,036)
                                    --------------    --------------   --------------    --------------     --------------
      Total Other Income (Expense)            (241)             (234)            (819)             (381)              (819)

NET LOSS BEFORE TAXES                     (171,952)          (70,586)        (850,539)          (95,390)        (1,341,475)
                                    --------------    --------------   --------------    --------------     --------------

Provision for income taxes                      --                --               --                --                 --
                                    --------------    --------------   --------------    --------------     --------------

NET LOSS                            $     (171,952)   $      (70,586)  $     (850,539)   $      (95,390)    $   (1,341,475)
                                    ==============    ==============   ==============    ==============     ==============
PER SHARE DATA:
  Basic and diluted income (loss)
   per common share                 $        (0.00)   $        (0.00)  $        (0.00)   $        (0.00)
                                    --------------    --------------   --------------    --------------
  Weighted average number of
   common shares outstanding         1,328,078,203     1,014,616,666    1,291,448,166       809,044,872
                                    ==============    ==============   ==============    ==============
</TABLE>

                                       4
<PAGE>
                                   Cytta Corp.
                          (A Development Stage Company)
                      Consolidated Statements of Cash Flows

<TABLE>
<CAPTION>
                                                                                                Cumulative from
                                                               For the Nine Months Ended          Inception on
                                                                       June 30,                 May 30, 2006 to
                                                            -------------------------------        June 30,
                                                                2011               2010              2011
                                                            ------------       ------------      ------------
<S>                                                         <C>                <C>               <C>
OPERATING ACTIVITIES
  Net income (loss)                                         $   (850,539)      $    (95,391)     $ (1,341,475)
  Adjustments to reconcile net income (loss) to net
   cash from operating activities:
     Depreciation and amortization                                    --                 --             3,419
     Impairment of licensing agreement                           325,000                 --           441,581
     Issuance of common stock for services and expenses               --                 --           187,570
     Operating expenses paid on behalf of the Company
      by a related party                                         198,500             16,660           253,892
  Changes in Operating Assets and Liabilities:
     Accounts payable and accrued laibilities                       (534)              (283)           15,188
     Inventory                                                    (5,440)                --            (5,440)
     Prepaid fees and services                                    51,935             73,662                --
                                                            ------------       ------------      ------------
          Net cash from operating activities                    (281,078)            (5,352)         (445,265)
                                                            ------------       ------------      ------------
INVESTING ACTIVITIES
  Investment in joint venture                                    (25,000)                --           (25,000)
  Purchase of property and equipment                              (7,262)                --            (7,262)
                                                            ------------       ------------      ------------
          Net cash from investing activities                     (32,262)                --           (32,262)
                                                            ------------       ------------      ------------
FINANCING ACTIVITIES
  Common stock issued for cash                                        --                 --           161,000
  Proceeds from stock subscriptions payable                      568,000                 --           568,000
  Advances from related parties                                  103,100              7,700           126,214
  Repayment of advances from related parties                    (163,094)                --          (163,094)
                                                            ------------       ------------      ------------
          Net cash from financing activities                     508,006              7,700           692,120
                                                            ------------       ------------      ------------

NET CHANGE IN CASH                                               194,666              2,348           214,593
CASH AT BEGINNING OF PERIOD                                       19,927                136                --
                                                            ------------       ------------      ------------
CASH AT END OF PERIOD                                       $    214,593       $      2,484      $    214,593
                                                            ============       ============      ============
SUPPLEMENTAL CASH FLOW DISCLOSURES
  Cash paid for interest                                    $         --       $         --      $         --
  Cash paid for income taxes                                $         --       $         --      $         --

NON-CASH INVESTING AND FINANCING ACTIVITIES
  Common stock issued for fees and services                 $         --       $    180,000      $     31,930
  Common stock issued for debt                                        --             31,930            31,930
  Common stock issued for licensing agreements              $    325,000       $         --      $    445,000
</TABLE>

                                       5
<PAGE>
                                   Cytta Corp.
                          (A Development Stage Company)
              Condensed Notes to Consolidated Financial Statements
                      June 30, 2011 and September 30, 2010


NOTE 1 - CONDENSED FINANCIAL STATEMENTS

The accompanying  financial statements have been prepared by the Company without
audit. In the opinion of management,  all adjustments (which include only normal
recurring  adjustments)  necessary  to present  fairly the  financial  position,
results of  operations,  and cash flows at June 30,  2011,  and for all  periods
presented herein, have been made.

Certain  information  and footnote  disclosures  normally  included in financial
statements prepared in accordance with accounting  principles generally accepted
in the United States of America have been condensed or omitted.  It is suggested
that  these  condensed  financial  statements  be read in  conjunction  with the
financial  statements and notes thereto included in the Company's  September 30,
2010 audited  financial  statements.  The results of  operations  for the period
ended June 30, 2011 is not necessarily  indicative of the operating  results for
the full year.

NOTE 2 - GOING CONCERN

The  Company's  financial  statements  are  prepared  using  generally  accepted
accounting  principles  in the United  States of America  applicable  to a going
concern  which  contemplates  the  realization  of  assets  and  liquidation  of
liabilities  in  the  normal  course  of  business.  The  Company  has  not  yet
established  an ongoing  source of revenues  sufficient  to cover its  operating
costs and allow it to continue as a going concern. The ability of the Company to
continue  as a going  concern is  dependent  on the Company  obtaining  adequate
capital to fund operating losses until it becomes profitable.  If the Company is
unable to obtain adequate capital, it could be forced to cease operations.

In order to continue as a going  concern,  the  Company  will need,  among other
things,  additional  capital  resources.  Management's  plan is to  obtain  such
resources for the Company by obtaining  capital from  management and significant
shareholders  sufficient  to meet its  minimal  operating  expenses  and seeking
equity and/or debt financing.  However  management cannot provide any assurances
that the Company will be successful in accomplishing any of its plans.

The ability of the Company to continue as a going concern is dependent  upon its
ability  to  successfully  accomplish  the  plans  described  in  the  preceding
paragraph and eventually secure other sources of financing and attain profitable
operations. The accompanying financial statements do not include any adjustments
that might be necessary if the Company is unable to continue as a going concern.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

USE OF ESTIMATES
The preparation of financial statements in conformity with accounting principles
generally  accepted in the United States of America requires  management to make
estimates  and  assumptions  that  affect  the  reported  amounts  of assets and
liabilities at the date of the financial  statements and the reported amounts of
revenue and expenses  during the reporting  period.  Actual results could differ
from those estimates.

RECENT ACCOUNTING PRONOUNCEMENTS
Below is a listing of the most recent accounting pronouncements issued since the
September 31, 2009 audited financial statements of the Company were released and
through  February 18, 2011. The Company has evaluated these  pronouncements  and
does not  expect  their  adoption  to have a  material  impact on the  Company's
financial position, or statements.

                                       6
<PAGE>
                                   Cytta Corp.
                          (A Development Stage Company)
              Condensed Notes to Consolidated Financial Statements
                      June 30, 2011 and September 30, 2010


NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

RECENT ACCOUNTING PRONOUNCEMENTS (CONTINUED)

     *    Accounting  Standards  Update 2010-17 Revenue  Recognition-  Milestone
          Method  (Topic  605):  Milestone  Method of  Revenue  Recognition  - a
          consensus of the FASB emerging issues task force. Effective for fiscal
          years on or after June 15, 2010.
     *    Accounting   Standards   Update  2010-12  Income  Taxes  (Topic  740):
          Accounting for Certain Tax Effects of the 2010 Health Care Reform Acts
          (SEC Update). Effective July 1, 2010.
     *    Accounting  Standards  Update  2010-11Derivatives  and Hedging  (Topic
          815):  Scope  Exception   Related  to  Embedded  Credit   Derivatives.
          Effective July 1, 2010.
     *    Accounting  Standards  Update 2010-09  Subsequent  Events (topic 855):
          Amendments  to  Certain   Recognition  and  Disclosure   Requirements.
          Effective July 1, 2010.
     *    Accounting  Standards  Update  2010-06  Fair  Value  Measurements  and
          Disclosures  (Topic  820):  Improving  Disclosures  about  Fair  Value
          Measurements. Effective July 1, 2010.
     *    Accounting  Standards Update 2010-05  Compensation-Stock  Compensation
          (Topic718):   Escrowed  share  arrangements  and  the  Presumption  of
          Compensation (SEC Update). Effective July 1, 2010.
     *    Accounting  Standards  Update  2010-04 (ASU  2010-04),  Accounting for
          Various Topics-Technical Corrections to SEC Paragraphs. Effective July
          1, 2010.

NOTE 3 - ACQUISITION OF LICENSING AGREEMENT

On November 10th,  2010, the Company entered into an MVNO Mobile Virtual Network
Operator Agreement (herein "MVNO Agreement") with Vonify Inc of Toronto,  Canada
and  Georgetown,  Grand Cayman  Island,  BWI (herein  "Vonify")  and MVNO Mobile
Virtual Network Operator Corp (herein "MVNO") of New  Westminster,  Canada for a
license to provide all the "Services" of the Vonify Network to third parties, in
the medical marketplace in the USA. The Vonify Network includes those integrated
mobile  switching   facilities,   servers,  cell  sites,  telecom  and  internet
connections,  billing systems,  validation systems, gateways,  landline switches
and other related  facilities  used to provide the Services.  The Services to be
marketed by Cytta are defined as wireless  telecommunications  services  for the
Global  System  for  Mobile  (GSM)  communications.  In  exchange  for the  MVNO
Agreement,  Cytta issued  250,000,000  shares of the  Company's  common stock to
Vonify on November 10, 2010. This  transaction  will result in Vonify becoming a
greater than 10% shareholder of the Company. In connection with the transaction,
a controlling shareholder of Vonify became a Director of the Company.

Subsequent to the transaction,  the Company determined the carrying value of the
licensing  agreement  to be less than the fair value of the asset.  As such,  in
accordance  with ASC 350-30-35 the Company has determined the value of the asset
to be fully  impaired  as of  December  31,  2010  and  recognized  $325,000  of
impairment expense during the nine month period ended June 30, 2010.

NOTE 4 - JOINT VENTURE

On June 24,  2011,  the Company  entered  into a joint  venture  agreement  with
Promia, Inc.,  ("Promia") to utilize Promia's  proprietary  information security
technologies to create security enabled software and hardware  solutions for the
Company. Under the terms of the joint venture agreement,  the Company has agreed
to install and market the Promia security  technology on all systems they deploy
in the United States and abroad and Promia has agreed to create the hardware and
software development  necessary to integrate their technology with the Company's
mobile network applications.

                                       7
<PAGE>
                                   Cytta Corp.
                          (A Development Stage Company)
              Condensed Notes to Consolidated Financial Statements
                      June 30, 2011 and September 30, 2010


NOTE 4 - JOINT VENTURE (CONTINUED)

To fulfill the objectives, the Company and Promia agreed to form a Joint Venture
LLC named Cytta Connects,  LLC ("JV"),  wherein 60 percent of the JV is owned by
the Company  and 40 percent of the JV is owed by Promia.  Under the terms of the
agreement,  initial  funding for the JV was to be $250,000 to be provided by the
Company.  As of June 30, 2011 the Company has funded $25,000 as an Investment in
Joint Venture and has been  accounted  for in accordance  with ASC 810 (see Note
5).

NOTE 5 - NONCONTROLLING INTEREST

On June 24,  2011,  the Company  entered  into a joint  venture  Agreement  with
Promia, Inc.,  ("Promia") to utilize Promia's  proprietary  information security
technologies to create security enabled software and hardware  solutions for the
Company. See Note 4 for description of Joint Venture.

Per the terms of the agreement, the JV is 60 percent is owned by the Company and
40  percent  by  Promia.  According  to ASC 810,  the  Company  is  required  to
consolidate the all the assets,  liabilities and operations of the JV and record
a  noncontrolling  interest for the portion of net assets  controlled  by Promia
within stockholders' equity.
 As of June 24th,  2011,  the  Company  recorded a  noncontrolling  interest  of
$10,000  or 40% of the net assets of $25,000  as a  noncontrolling  interest  to
Promia. As of June 30, 2011, the JV did not have any operations or expenses.

NOTE 6 - RELATED PARTY NOTES PAYABLE

As of June 30, 2011 and  September  30, 2010 the Company  owed  various  related
parties  $191,531 and $53,026,  respectively.  The notes are unsecured,  bear no
interest and are due on demand.

NOTE 7 - STOCKHOLDERS' EQUITY

COMMON STOCK ISSUANCES
During the period ended June 30, 2011, the Company's Board of Directors resolved
to issue  250,000,000  shares of common stock in a  non-monetary  transaction to
acquire a licensing agreement at $0.0013 per share.

COMMON STOCK SUBSCRIPTIONS
During the period  ended June 30,  2011,  the  Company  received  $301,000  from
related  parties and $221,000  from related  parties and $80,000 from  unrelated
third  parties in exchange  for  267,251,516  shares of common stock and no less
than 2,100,000 convertible preferred shares to be issued at a future date. These
amounts have been recorded as stock  subscriptions  in the  Company's  financial
statements.  As of the date of this report,  the Company has not  satisfied  its
subscriptions obligation through the issuance of shares of stock.

On March 31, 2011, the Company provided an offering to potential  investors of a
maximum of 10 units at $25,000 per unit or $0.001 per share.  Each unit  consist
of  25,000,000  shares of common stock and  25,000,000  warrants to purchase the
Company's  common stock at $0.01 per share.  The warrants are exercisable at any
time from their initial issue date until March 30, 2012.

During the period ended June 30, 2011, the Company sold 10.98 units and received
$267,000  in cash  which  has been thus been  recorded  as a stock  subscription
payable until upon such time that the Company issues the shares of common stock.

                                       8
<PAGE>
                                   Cytta Corp.
                          (A Development Stage Company)
              Condensed Notes to Consolidated Financial Statements
                      June 30, 2011 and September 30, 2010


Each warrant is exercisable are exercisable at any time from their initial issue
date until March 30, 2012 at an exercise price of $0.01 per shares. The warrants
were valued using the  Black-Scholes  Option  Pricing  model using the following
assumptions: 1 year or less term, $0.09-$0.19 stock price, $0.01 exercise price,
180-221%  volatility,  0.22-0.80%  risk free rate.  The  Company  has  allocated
$51,865 of the total $267,000 proceeds to the value of the warrants.

NOTE 6 - WARRANTS

During the period ended June 30, 2011, the Company issued  269,500,000  warrants
in  conjunction  with the  stock  offering  noted in Note 5.  The  warrants  are
exercisable at $0.01 per share and expire on March 30, 2012.

Summary information regarding common stock warrants issued and outstanding as of
June 30, 2011 is as follows:

                                                                      Weighted
                                                                      Average
                                                 Warrants           Share Price
                                                 --------           -----------

     Outstanding at September 30, 2010                  --            $   --
       Granted                                 269,500,000              0.01
       Exercised                                        --                --
       Expired                                          --                --
                                               -----------            ------
     Outstanding at June 30, 2011              269,500,000            $ 0.01
                                               ===========            ======


Summary  of  warrants  outstanding  and  exercisable  as of June 30,  2011 is as
follows:

                       Outstanding                          Exercisable
     Exercise           Number of         Remaining          Number of
      Price              Shares             Life              Shares
      -----              ------             ----              ------

     $ 0.01            269,500,000          0.67           269,500,000

NOTE 8 - SUBSEQUENT EVENTS

In accordance with ASC 855-10 the Company has evaluated all material  subsequent
events from the balance  sheet date through the date of this report.  There have
been no other reportable subsequent events.

                                       9
<PAGE>
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS

FORWARD-LOOKING STATEMENTS

Except  for  historical  information,   this  report  contains   forward-looking
statements  within the meaning of Section 27A of the  Securities Act of 1933 and
Section  21E of  the  Securities  Exchange  Act of  1934.  Such  forward-looking
statements  involve  risks and  uncertainties,  including,  among other  things,
statements  regarding our business  strategy,  future  revenues and  anticipated
costs and expenses. Such forward-looking statements include, among others, those
statements including the words "expects,"  "anticipates,"  "intends," "believes"
and similar  language.  Our actual results may differ  significantly  from those
projected  in the  forward-looking  statements.  Factors  that  might  cause  or
contribute to such differences  include, but are not limited to, those discussed
herein as well as in the "Description of Business - Risk Factors" section in our
Annual  Report on Form 10-K for the year ended  September  30, 2010.  You should
carefully review the risks described in our Annual Report and in other documents
we file from time to time with the Securities and Exchange  Commission.  You are
cautioned not to place undue reliance on the forward-looking  statements,  which
speak only as of the date of this report. We undertake no obligation to publicly
release any revisions to the  forward-looking  statements  or reflect  events or
circumstances after the date of this document.

Although we believe that the  expectations  reflected  in these  forward-looking
statements are based on reasonable assumptions,  there are a number of risks and
uncertainties  that could cause actual  results to differ  materially  from such
forward-looking statements.

All references in this Form 10-Q to the "Company," "Cytta," "we," "us," or "our"
are to Cytta Corp.

RESULTS OF OPERATIONS

We are a development  stage  corporation.  We have generated  $2,000 in revenues
from our business  operations  since  inception (May 30, 2006) and have incurred
$1,341,296 in expenses through June 30, 2011.

The following  table  provides  selected  financial data about our company as of
June 30, 2011 and September 30th, 2010, respectively.

     Balance Sheet Data                 June 30, 2011     September 30, 2010
     ------------------                 -------------     ------------------

     Cash and cash equivalents            $214,593             $ 19,927
     Total Assets                         $252,295             $ 71,862
     Total Liabilities                    $200,270             $ 62,298
     Shareholder Equity (Deficit)         $ 52,025             $  9,564

Net cash used by operating  activities  since  inception  (May 30, 2006) through
June 30, 2011 was $445,265.

                                       10
<PAGE>
PLAN OF OPERATION

On June  18th,  2009,  the  Company  entered  into a  Licensing  Agreement  with
Lifespan,  Inc.  Through  a series of  transactions  and  business  developments
commencing  in  2002  Lifespan  had  acquired  the  expertise  and  licenses  to
manufacture,  distribute and market various technology based internet access and
computing products and services,  consisting of internet access devices, related
software and hardware and a series of medical  peripherals  designed and adapted
to provide remote non-diagnostic monitoring of home based and remote patients.

Under the terms of the Agreement  with Cytta,  Lifespan  granted the Company the
exclusive license to manufacture,  sell,  distribute,  operate,  sub-license and
market  these  internet  access  devices,  products  and  services in the United
States.  The Company has been  utilizing  the License to develop a model for the
internet access devices which can incorporate the numerous  technology  advances
which are currently available and is currently pursuing this avenue. In exchange
for the  license,  Lifespan  has received  120,000,000  shares of the  Company's
common  stock,  plus a license fee equal to one half of one percent (.5%) of the
net revenue  derived from the sale and use of their products and services.  This
transaction is more fully described in our Current Report on Form 8-K filed with
the Securities and Exchange Commission on June 19, 2009.

On November 10th,  2010, the Company entered into an MVNO Mobile Virtual Network
Operator Agreement (herein "MVNO Agreement") with Vonify Inc of Toronto,  Canada
and  Georgetown,  Grand Cayman  Island,  BWI (herein  "Vonify")  and MVNO Mobile
Virtual Network Operator Corp (herein "MVNO") of New  Westminster,  Canada for a
license to provide all the  "Services" of the Vonify  Network to third  parties,
initially in the medical marketplace in the USA.

The Vonify  Network  includes  those  integrated  mobile  switching  facilities,
servers,  cell  sites,  telecom  and  internet  connections,   billing  systems,
validation  systems,  gateways,  landline switches and other related  facilities
used to provide the  Services.  The Services to be marketed by Cytta are defined
as wireless  telecommunications  services for the Global System for Mobile (GSM)
communications.

In exchange  for the MVNO  Agreement,  Cytta  issued  250,000,000  shares of the
Company's common stock to Vonify Inc. This  transaction  resulted in Vonify Inc.
becoming a greater than 10% shareholder of the Company.  Mr. William  Becker,  a
Director of the  Company,  is a  controlling  shareholder  of Vonify  Inc.  This
transaction is more fully described in our Current Report on Form 8-K filed with
the Securities and Exchange Commission on November 29, 2010.

Since the acquisition of the Lifespan technology,  and the rights to utilize the
Vonify  cellular  network through the MVNO  Agreement,  the Company  developed a
remote medical  monitoring model designed to deliver  seamless,  near real-time,
medical  data  transmission  from home to  Insurer.  The  Company's  system  was
designed to  seamlessly  collect the data  generated  by the home based  medical
monitoring devices (such as blood pressure,  scale, blood glucose,  pulse oxygen
etc),  utilizing  Bluetooth  connectivity.  This medical data is seamlessly sent
from the  medical  device to the  Company's  Medical  Smartphone,  which is also
located in the home.  The Company's  Medical  Smartphone,  contains  proprietary
programming,  consisting  of a "Firmware  Client",  which when  installed on the
Cytta Medical Smartphone,  automatically  receives the medical data and utilizes

                                       11
<PAGE>
the Company's wireless telecommunication  services, to transmit the data through
the cellular network to the Online Cytta Data repository.  From the Online Cytta
Data  repository  the data can be  automatically  transmitted  to the electronic
medical  monitoring  systems  (EMR's)  of the  major  Medical  Groups  (such  as
Insurance   Companies,    Disease   Management   Companies,    Health   Delivery
Organizations,  Health Plans, Home Health Agencies,  Managed Care Organizations,
Medical  Groups  and IPAs) who have  placed  the  systems  in the homes of their
clients  requiring remote  monitoring.  These Medical Groups contract with Cytta
and are  responsible  for placing  the system in the homes of their  clients who
require monitoring.

The  Company  has now  finalized  the  testing of the  Vonify  network in the US
utilizing  Vonify  SIM cards  installed  on Nexus  One and My Touch HTC  android
smartphones  deployed in various parts of the US. After  comprehensive  testing,
the Cytta network was found to be fully  functional  and compliant in regards to
voice,  data and SMS  connectivity.  The  network is suitable in all aspects for
utilization  by Cytta for the  movement  of medical  information  gathered  from
Bluetooth  enabled  remote  medical  monitoring   devices.   The  Cytta  Medical
smartphones are also fully functional voice, data and SMS cell phones.

The Company  plans on  incorporating  medical  monitoring  devices to measure of
Blood  Pressure,  Glucose  Values,  Weight,  PT/INR,  ECG Rhythms,  Respiration,
Temperature, Pulse, and Oxygen Saturation into the Cytta Ecosystem.

The Company and its  development  partners have now completed the development of
the  proprietary  Firmware  Client and have  installed the technology on several
Nexus One and HTC My Touch android  smartphones.  The testing of the combination
Smartphone and Firmware  Client,  which has  collectively  been described as the
Cytta Medical Smartphone,  with the blood pressure, weight scale, pulse/oximetry
and blood glucose devices has been completed and are all functioning seamlessly.

The Company and its partners are now completing  the  development of the `Online
Data Presentation  Screens" to represent the data captured by the system for its
potential clients.  Upon completion of the Online Data Presentation  Screens and
acquisition and  programming of a supply of suitable  android  smartphones,  the
Company will begin  installing  the complete  Cytta  Ecosystems  in several test
locations in the US, with potential Medical Group clients wishing to utilize and
or participate in the Company's "medical monitoring ecosystem'.  Upon conclusion
of testing,  the Company will begin its  deployment  of its systems and commence
operations as a Medical Health Service Provider (MHSP).

The Company's  integrated and completely  autonomous  system  provides  numerous
advantages  over current  systems,  as well as a pricing  structure  designed to
generate a positive return on investment  (ROI) for the Medical Groups utilizing
the system.  To this end the Company is  currently  demonstrating  the system to
numerous  potential  device  manufacturing  partners and Medical  Group  clients
wishing to utilize  and or  participate  in the  Company's  "medical  monitoring
ecosystem".

In an effort to  respond  to  numerous  data  security  concerns  related to the
transmission of information  through a mobile  communications  network,  on June
24th,  2011,  the Company  entered into a Joint Venture and Value Added Reseller
Agreement (herein the "Agreement") with Promia, Inc of San Francisco, Ca (herein
"Promia") to utilize Promia's software and hardware development services and

                                       12
<PAGE>
technologies  to create  robust  and  security  enabled  software  and  hardware
solutions for the Cytta Medical  Ecosystem  and the Cytta mobile  network.  This
transaction is more fully described in our Current Report on Form 8-K filed with
the Securities and Exchange Commission on June 30, 2011

Cytta currently has minimal operating costs and expenses at the present time due
to our relatively new business activities.  However we anticipate  significantly
increasing  our  activities as a result of the MVNO  Agreement.  We have entered
into certain  management and consulting  contracts with our senior  Officers and
non  affiliated  consultants  who will be  providing  business  services  to the
Company in the health  care  arena.  Additionally,  we will be required to raise
significant  capital  over  the  next  twelve  months,  in  connection  with our
operations resulting from our marketing  Agreements.  We do not currently engage
in any product  research and  development  however the  Company's  Joint Venture
Agreement  and  marketing  Agreements  may cause us to engage  in  research  and
development in the foreseeable  future.  We have no present plans to purchase or
sell any plant or  significant  equipment  although we will have to acquire some
equipment related to the marketing  Agreements.  We also have no immediate plans
to add employees, other than the current management and consultants, although we
may do so in the future as a result of the  operations  related to the marketing
Agreements.

LIQUIDITY AND CAPITAL RESOURCES

Our cash and cash equivalents balance as of June 30, 2011 was $214,593.

We  are a  development  stage  company  and  currently  have  limited  marketing
operations.

We do not have  sufficient  funds on hand to pursue our business  objectives for
the near future or to commence full scale operations  without seeking additional
funding.  We  currently  do not have a specific  plan of how we will obtain such
funding.

LOANS TO THE COMPANY

We have been  receiving  loans from  shareholders  of the company to pay general
operating costs. As of June 30, 2011, we had $191,531 in loans outstanding.

We have  minimal  operating  costs and  expenses at the present  time due to our
limited  business   activities.   Currently  our  operating  activities  in  the
healthcare  arena are conducted by our senior Officers and engaged  consultants.
We will,  however,  be required to raise additional capital over the next twelve
months  to  meet  our  current  administrative   expenses  and  to  develop  our
operations.  This financing may take the form of additional  sales of our equity
or debt  securities  to, or loans from,  stockholders,  or from our officers and
directors or other individuals.  There is no assurance that additional financing
will be available from these or other sources, or, if available, that it will be
on terms favorable to us.

GOING CONCERN

Our  auditors  have  included an  explanatory  paragraph  in their report on our
financial  statements  relating to the  uncertainty  of our  business as a going
concern,   due  to  our  limited  operating  history,  our  lack  of  historical
profitability,  and our limited funds.  We believe that we will be able to raise
the required funds for operations and to achieve our business plan.

                                       13
<PAGE>
OFF-BALANCE SHEET ARRANGEMENTS

We have never entered into any off-balance sheet financing arrangements and have
not formed any special purpose  entities with the exception of the Cytta Connect
LLC joint  venture.  We have not  guaranteed  any debt or  commitments  of other
entities or entered into any options on non-financial assets.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4T. CONTROLS AND PROCEDURES

EVALUATION OF OUR DISCLOSURE CONTROLS

Under the  supervision  and with the  participation  of our  senior  management,
including  our chief  executive  officer and chief  financial  officer,  Stephen
Spalding,  we conducted an  evaluation  of the  effectiveness  of the design and
operation  of our  disclosure  controls  and  procedures,  as  defined  in Rules
13a-15(e) and 15d-15(e)  under the  Securities  Exchange Act of 1934, as amended
(the  "Exchange  Act"),  as of the end of the period  covered by this  quarterly
report (the "Evaluation  Date").  Based on this evaluation,  our chief executive
officer and chief financial officer concluded as of the Evaluation Date that our
disclosure  controls and procedures were not effective such that the information
relating  to us,  required  to be  disclosed  in  our  Securities  and  Exchange
Commission ("SEC") reports (i) is recorded,  processed,  summarized and reported
within  the  time  periods  specified  in SEC  rules  and  forms,  and  (ii)  is
accumulated and  communicated  to our management,  including our chief executive
officer and chief financial  officer,  as appropriate to allow timely  decisions
regarding required disclosure.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

There have been no changes in our internal control over financial reporting that
occurred during the quarter ended June 30, 2011 that have materially affected or
are reasonably  likely to materially  affect our internal control over financial
reporting.

                           PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

In the ordinary course of our business,  we may from time to time become subject
to routine litigation or administrative  proceedings which are incidental to our
business.  We are not a party to nor are we aware of any  existing,  pending  or
threatened lawsuits or other legal actions involving us.

ITEM 1A. RISK FACTORS

Not applicable.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

                                       14
<PAGE>
ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

The following exhibits are included as part of this report:

Exhibit No.                           Description
-----------                           -----------

31.1 / 31.2       Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal
                  Executive and Financial Officer

32.1 / 32.2       Rule 1350 Certification of Principal Executive and Financial
                  Officer

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

CYTTA CORP.

Dated: August 19, 2011


By: /s/ Stephen Spalding
   ----------------------------------------------
   Stephen Spalding
   CEO, Principal Executive and Financial Officer


                                       15